66
Views
3
CrossRef citations to date
0
Altmetric
Review

The RTOG Outcomes Model: economic end points and measures

&
Pages 513-519 | Published online: 02 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hind T Hatoum, E David Crawford, Sandy Kildegaard Nielsen, Swu-Jane Lin & Dennis C Marshall. (2013) Cost–effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer. Expert Review of Pharmacoeconomics & Outcomes Research 13:2, pages 261-270.
Read now

Articles from other publishers (2)

M. Barbieri, H. L. A. Weatherly, R. Ara, H. Basarir, M. Sculpher, R. Adams, H. Ahmed, C. Coles, T. Guerrero-Urbano, C. Nutting & M. Powell. (2014) What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer. Applied Health Economics and Health Policy 12:5, pages 497-510.
Crossref
Julie B. Schnur, Joshua Graff Zivin, David M. K. MattsonJr.Jr., Sheryl Green, Lina H. Jandorf, A. Gabriella Wernicke & Guy H. Montgomery. (2012) Acute skin toxicity-related, out-of-pocket expenses in patients with breast cancer treated with external beam radiotherapy. Supportive Care in Cancer 20:12, pages 3105-3113.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.